On April 20, NCI Director John E. Niederhuber, MD,
announced details about the Institute’s plan to use the stimulus
funding allocated in the American Recovery and Reinvestment Act. Also,
last week, The New York Times published an article highlighting cost
of care issues faced by some people with cancer who are prescribed
oral chemotherapy drugs.